#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Waldenstrom's macroglobulinaemia Cutaneous calcification Leukoencephalopathy Juvenile idiopathic arthritis Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Anal fistula B-cell type acute leukaemia Toxic epidermal necrolysis Acquired C1 inhibitor deficiency Interstitial lung disease Epstein-Barr virus infection Neurodermatitis Malignant fibrous histiocytoma Acute leukaemia Round cell liposarcoma More trials…

    Learn about Rare Diseases

    Angiosarcoma metastatic – Diagnostics Kearns-Sayre syndrome – Diagnostics Mucopolysaccharidosis III – Trials in Disease Mantle cell lymphoma stage IV – Treatment Indolent systemic mastocytosis – Diagnostics Adrenogenital syndrome – Basic Information Krabbe’s disease Ewing’s sarcoma metastatic – Trials in Disease Hyperoxaluria – Trials in Disease Glycogen storage disease type V – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Povetacicept Antithrombin Iii Human Esflurbiprofen PALAZESTRANT Ltx-315 Posdinemab Levamlodipine Succinate Tirzepatide Ly3541860 Obinutuzumab Pehero Lutikizumab SAR444336 Ribonucleic Acid Empasiprubart CYCLIZINE HYDROCHLORIDE Tafamidis Cyclophosphamide Sym023 Fasudil Hydrochloride More therapies…

    Learn about Your Condition

    Small fibre neuropathy Pseudomyxoma peritonei Restless legs syndrome Lymphatic malformation Cardiac sarcoidosis Neurogenic bladder Adenocarcinoma of colon Renal injury Chronic hepatic failure Lymphoma Malignant peritoneal neoplasm Periodontitis Vaginal infection Stomatitis Shprintzen-Goldberg syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on Atorvastatin for Preventing Episodic Migraine in Adults

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Atorvastatin
    • Placebo
    Norway

  • Study on Atorvastatin for Preventing Chronic Migraine in Adults

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Atorvastatin
    • Placebo
    Norway

  • Study of ApTOLL for Treating Acute Ischemic Stroke in Patients Before Hospital Arrival

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Aptamer-4Ft
    Spain

  • Study on Gene Therapy with AAVrh10 for Infants with Krabbe Disease Undergoing Stem Cell Transplantation

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Krabbe’s disease
    Investigated Drugs:
    • Adeno-Associated Virus Serotype Rh10 Containing The Human Galc Gene
    Spain

  • Safety Study of Afamelanotide for Patients with Early Parkinson’s Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Afamelanotide
    Italy

  • Study on JNJ-64042056 for Preclinical Alzheimer’s Disease in Patients

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Jnj-64042056
    Belgium France Germany Spain Sweden
Previous Page
1 … 78 79 80 81 82 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!